Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 25% ± 6% | |
epithelial cell | 5 studies | 31% ± 12% | |
astrocyte | 5 studies | 21% ± 3% | |
oligodendrocyte | 5 studies | 20% ± 3% | |
ciliated cell | 4 studies | 22% ± 7% | |
abnormal cell | 4 studies | 26% ± 9% | |
B cell | 3 studies | 20% ± 3% | |
classical monocyte | 3 studies | 19% ± 3% | |
conventional dendritic cell | 3 studies | 36% ± 13% | |
microglial cell | 3 studies | 19% ± 3% | |
macrophage | 3 studies | 38% ± 23% | |
GABAergic neuron | 3 studies | 28% ± 3% | |
glutamatergic neuron | 3 studies | 37% ± 6% | |
oligodendrocyte precursor cell | 3 studies | 23% ± 5% | |
dendritic cell | 3 studies | 24% ± 7% | |
natural killer cell | 3 studies | 17% ± 1% | |
neuron | 3 studies | 27% ± 10% | |
plasmacytoid dendritic cell | 3 studies | 21% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2616.65 | 459 / 459 | 100% | 89.45 | 1118 / 1118 |
esophagus | 100% | 2969.43 | 1445 / 1445 | 100% | 62.00 | 183 / 183 |
liver | 100% | 1782.76 | 226 / 226 | 100% | 67.98 | 406 / 406 |
ovary | 100% | 2557.95 | 180 / 180 | 100% | 52.41 | 430 / 430 |
prostate | 100% | 2956.91 | 245 / 245 | 100% | 67.01 | 502 / 502 |
stomach | 100% | 2813.22 | 359 / 359 | 100% | 61.89 | 286 / 286 |
uterus | 100% | 2841.34 | 170 / 170 | 100% | 66.58 | 459 / 459 |
thymus | 100% | 2718.84 | 653 / 653 | 100% | 54.06 | 604 / 605 |
lung | 100% | 2603.52 | 577 / 578 | 100% | 65.10 | 1155 / 1155 |
intestine | 100% | 3485.70 | 966 / 966 | 100% | 60.75 | 526 / 527 |
bladder | 100% | 2858.10 | 21 / 21 | 100% | 54.42 | 503 / 504 |
kidney | 100% | 2658.36 | 89 / 89 | 100% | 52.52 | 899 / 901 |
pancreas | 100% | 2068.50 | 327 / 328 | 100% | 63.90 | 178 / 178 |
brain | 100% | 2171.79 | 2633 / 2642 | 100% | 67.18 | 705 / 705 |
adrenal gland | 100% | 3451.22 | 258 / 258 | 99% | 43.77 | 228 / 230 |
skin | 100% | 2927.32 | 1808 / 1809 | 99% | 62.74 | 466 / 472 |
adipose | 100% | 2764.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.57 | 29 / 29 |
muscle | 100% | 7284.90 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2759.99 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 49.76 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 39.25 | 1 / 1 |
blood vessel | 100% | 2593.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 3079.05 | 843 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 32.35 | 76 / 80 |
peripheral blood | 87% | 1875.87 | 808 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007584 | Biological process | response to nutrient |
GO_0008611 | Biological process | ether lipid biosynthetic process |
GO_0070542 | Biological process | response to fatty acid |
GO_0061024 | Biological process | membrane organization |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0042594 | Biological process | response to starvation |
GO_0019432 | Biological process | triglyceride biosynthetic process |
GO_0008654 | Biological process | phospholipid biosynthetic process |
GO_0021587 | Biological process | cerebellum morphogenesis |
GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
GO_0007416 | Biological process | synapse assembly |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0030913 | Biological process | paranodal junction assembly |
GO_0005778 | Cellular component | peroxisomal membrane |
GO_0016020 | Cellular component | membrane |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005777 | Cellular component | peroxisome |
GO_0005829 | Cellular component | cytosol |
GO_0005782 | Cellular component | peroxisomal matrix |
GO_0004366 | Molecular function | glycerol-3-phosphate O-acyltransferase activity |
GO_0016287 | Molecular function | glycerone-phosphate O-acyltransferase activity |
Gene name | GNPAT |
Protein name | Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DAPAT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase) Glyceronephosphate O-acyltransferase Dihydroxyacetone phosphate acyltransferase (EC 2.3.1.42) (Glycerone-phosphate O-acyltransferase) |
Synonyms | DHAPAT DAPAT |
Description | FUNCTION: Dihydroxyacetonephosphate acyltransferase catalyzing the first step in the biosynthesis of plasmalogens, a subset of phospholipids that differ from other glycerolipids by having an alkyl chain attached through a vinyl ether linkage at the sn-1 position of the glycerol backbone, and which unique physical properties have an impact on various aspects of cell signaling and membrane biology. . FUNCTION: Dihydroxyacetonephosphate acyltransferase catalyzing the first step in the biosynthesis of plasmalogens, a subset of phospholipids that differ from other glycerolipids by having an alkyl chain attached through a vinyl ether linkage at the sn-1 position of the glycerol backbone, and which unique physical properties have an impact on various aspects of cell signaling and membrane biology. . |
Accessions | Q5TBH6 O15228 Q5TBH8 ENST00000644483.1 ENST00000366647.9 [O15228-1] ENST00000416000.1 ENST00000436239.5 A0A2R8YH69 |